Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears Heart Force's ballistocardiograph

This article was originally published in Clinica

Executive Summary

A digital ballistocardiograph (dBG) developed by Heart Force Medical has received 510(k) clearance from the US FDA. The dBG 300 device is a standalone, portable noninvasive cardiac performance monitor; it employs digital sensors to measure the recoil of the human body due to the momentum of the blood pumped by the heart. Vancouver, Canada-based Heart Force Medical intends the device to be used to monitor patients in critical care, as well as assessing cardiac performance other patients.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043986

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel